Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

CBT-Based Stress Management Program for Healthcare Students (CBT-SMP)

29 de septiembre de 2026 actualizado por: Kevser Pamuk, Afyonkarahisar Health Sciences University

Effectiveness of a Cognitive-Behavioral-Based Stress Management Skills Program in Healthcare Students: A Mixed-Methods Study

This study aims to evaluate the effectiveness of a cognitive-behavioral-based stress management skills program for healthcare students. The study will use a mixed-methods design and will include intervention, placebo, and control groups. Approximately 90 healthcare students will participate in the experimental phase. The intervention group will receive a 9-session cognitive-behavioral-based stress management program designed to help students recognize and manage stress, identify dysfunctional thoughts, and develop effective stress management and coping skills. The study will assess changes in perceived stress and coping skills before and after the program and at follow-up. Qualitative interviews and group discussions will also be conducted to explore students' experiences and perceptions of stress management and the program. It is hypothesized that students who participate in the stress management program will show improvements in perceived stress and coping skills compared with students in the placebo and control groups.

Descripción general del estudio

Descripción detallada

This study is designed as a nested mixed-methods study to evaluate the effectiveness of a cognitive-behavioral-based stress management skills program developed for healthcare students. The study consists of three phases. In the first phase, semi-structured individual interviews will be conducted to explore healthcare students' sources and experiences of stress and their coping strategies. Findings from this qualitative phase will contribute to the development and refinement of the intervention program.

In the second phase, an experimental study will be conducted using intervention, placebo, and control groups. Participants will be assigned to the three groups using computer-supported full randomization. The intervention group will participate in a 9-session cognitive-behavioral-based group program designed to develop stress management and coping skills. The placebo group will participate in a program distinct from the cognitive-behavioral-based intervention, while the control group will not receive an intervention during the study period. Quantitative and qualitative data will be collected during this phase. The quantitative assessment will be conducted at three time points: before the intervention, immediately after completion of the intervention, and 12 weeks after the intervention. To reduce potential researcher effects and measurement bias, quantitative data collection will be conducted by a researcher who is independent of the intervention facilitators.

In addition to quantitative assessments, participants in the intervention group will complete a session evaluation form after each session to provide information about the content, implementation process, participant interaction, and perceived benefits of the sessions. In the third phase, a focus group interview will be conducted with students who complete the intervention program to explore their views regarding the content, feasibility, and perceived effectiveness of the program. The qualitative findings obtained throughout the study will be integrated with the quantitative findings to provide a comprehensive evaluation of the intervention.

Qualitative data obtained from the semi-structured interviews, session evaluation forms, and focus group interview will be analyzed using content analysis. Quantitative data will be analyzed using two-way repeated-measures analysis of variance to examine the effects of group and time on perceived stress and coping skills. Appropriate assumption tests and corrections will be applied where necessary. Intention-to-treat and per-protocol analyses will be used to address potential participant loss or missing data.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

90

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

      • Afyonkarahisar, Turquía (Türkiye)
        • Afyonkarahisar Health Sciences University Faculty of Health Sciences, Department of Nursing
        • Contacto:
        • Contacto:
        • Investigador principal:
          • Kevser Pamuk, PhD
        • Sub-Investigador:
          • Ömer Faruk Akbulut, PhD
        • Sub-Investigador:
          • Beyza Yavuz, PhD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Be an active student in an associate or undergraduate program at the university.
  • Be willing to participate in the study.
  • Be 18 years of age or older.
  • Have sufficient time to attend all sessions of the program.
  • Agree to complete the pre-test, post-test, and follow-up assessments.
  • Be able to read and write in Turkish.

Exclusion Criteria:

  • Have a history of a psychiatric diagnosis (e.g., major depressive disorder, bipolar disorder, or psychotic disorder).
  • Be currently receiving psychotherapy or psychiatric treatment.
  • Regularly use psychiatric medication (e.g., antidepressants, antipsychotics, or anxiolytics).
  • Have participated in a similar stress management, mindfulness, or cognitive-behavioral-based training/program within the previous 6 months.
  • Be unable to attend the sessions regularly (e.g., due to prolonged absence or being away from the city).
  • Have a condition that interferes with communication (e.g., hearing, visual, or speech impairment).
  • Decline participation after randomization.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Cognitive-Behavioral-Based Stress Management Skills Program

Participants in this arm will receive a 9-session cognitive-behavioral-based stress management skills program designed to improve stress management and coping skills. The sessions will be conducted as a structured group intervention in accordance with the study protocol.

A 9-session cognitive-behavioral-based stress management skills program designed for health sciences students. The program is delivered as a structured group intervention and aims to improve participants' stress management and coping skills. Each session is conducted in accordance with the study protocol.

Comparador de placebos: Group Interaction and Guidance Activities

Participants in this arm will participate in group guidance activities that are not directly related to stress management but are designed to increase awareness of general social and life skills. The sessions will involve structured group activities and group interaction and will be conducted in accordance with the study protocol.

Participants in this arm will participate in group guidance activities that are not directly related to stress management but are designed to increase awareness of general social and life skills. The sessions will involve structured group activities and group interaction and will be conducted in accordance with the study protocol.

Sin intervención: No Intervention Control Group

Participants in this arm will not receive any intervention during the intervention period and will only participate in the scheduled outcome assessments. After completion of the data collection process, participants in the control group will be offered the cognitive-behavioral-based stress management skills program in accordance with the ethical principles of the study.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Perceived Stress Level
Periodo de tiempo: Baseline (pre-intervention), immediately after the intervention, and 12 weeks after the intervention

Perceived Stress Scale (PSS): Perceived stress levels will be assessed using the 14-item Perceived Stress Scale developed by Cohen et al. (1983) and adapted into Turkish by Eskin et al. (2013). Each item is rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often). The total score ranges from 0 to 56, with higher scores indicating higher levels of perceived stress and therefore a worse outcome. The scale consists of two subdimensions: inadequate self-efficacy perception and perception of stress/distress. Items 4, 5, 6, 7, 9, 10, and 13 are reverse scored.

Baseline (pre-intervention), immediately after the intervention, and 12 weeks after the intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Stress Coping Skills
Periodo de tiempo: Baseline (pre-intervention), immediately after the intervention, and 12 weeks after the intervention

Coping Inventory for Stressful Situations-Short Form: Coping strategies for dealing with stress will be assessed using the 21-item Coping Inventory for Stressful Situations-Short Form developed by Endler and Parker (1999) and adapted into Turkish by Boysan (2012). Each item is rated on a 5-point Likert scale ranging from 1 (not at all like me) to 5 (entirely like me). The total score ranges from 21 to 105. The scale consists of three subdimensions: problem-focused coping, emotion-focused coping, and avoidant coping. Higher scores on each subscale indicate a higher level of the corresponding coping strategy.

Baseline (pre-intervention), immediately after the intervention, and 12 weeks after the intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Kevser Pamuk, PhD, Afyonkarahisar Health Sciences University Faculty of Health Sciences, Department of Nursing

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

20 de octubre de 2026

Finalización primaria (Estimado)

30 de noviembre de 2026

Finalización del estudio (Estimado)

30 de abril de 2027

Fechas de registro del estudio

Enviado por primera vez

23 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

29 de septiembre de 2026

Publicado por primera vez (Actual)

1 de octubre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

1 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

29 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • AfyonkarahisarHSU-KPAMUK-2
  • 26.GENEL.022 (Otro número de subvención/financiamiento: Afyonkarahisar Health Sciences University Scientific Research Projects Coordination Unit)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be shared with other researchers because no plan for sharing individual participant data was established in the study protocol.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir